News

Categories

November 7, 2023

Zymeworks Provides Corporate Update And Reports Third Quarter 2023 Financial Results

November 1, 2023

Zymeworks Announces Participation in Upcoming Investor Conferences

October 17, 2023

Zymeworks To Host Third Quarter 2023 Results Conference Call

October 16, 2023

Zymeworks Announces New Director Nominee

October 16, 2023

Jazz Pharmaceuticals to Showcase Growing Impact in Solid Tumor Oncology Research at ESMO 2023

August 10, 2023

Zymeworks Provides Corporate Update and Reports Second Quarter 2023 Financial Results

August 1, 2023

Zymeworks Announces Participation in Upcoming Investor Conferences

July 19, 2023

Zymeworks To Host Second Quarter 2023 Results Conference Call

July 3, 2023

Zymeworks Announces Participation in Upcoming Investor Conference

June 29, 2023

Zymeworks Appoints New Director

June 26, 2023

Zymeworks Set To Join Russell 3000®, Russell 2000®, And Russell Microcap® Indexes

June 2, 2023

Jazz Pharmaceuticals and Zymeworks Present Positive Pivotal Phase 2b Trial Data at ASCO 2023 Evaluating Zanidatamab in HER2-Amplified Biliary Tract Cancers